| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/25/2013 | US20130189264 A novel chimeric protein for prevention and treatment of hiv infection |
| 07/25/2013 | US20130189263 Antigen-binding molecule and uses thereof |
| 07/25/2013 | US20130189261 TCR Complex Immunotherapeutics |
| 07/25/2013 | US20130189260 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer |
| 07/25/2013 | US20130189259 Anti-glycoprotein vi scfv fragment for treatment of thrombosis |
| 07/25/2013 | US20130189258 Therapeutic methods using anti-cd200 antibodies |
| 07/25/2013 | US20130189256 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 07/25/2013 | US20130189255 Fusions and conjugates of insulinotropic agents |
| 07/25/2013 | US20130189254 Inhibition of AXL/GAS6 Signaling in the Treatment of Disease |
| 07/25/2013 | US20130189252 Antibodies to receptor for advanced glycation end products (rage) and uses thereof |
| 07/25/2013 | US20130189251 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 07/25/2013 | US20130189250 Human Tissue Factor Antibody and Uses Thereof |
| 07/25/2013 | US20130189249 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| 07/25/2013 | US20130189247 Multimeric Proteins Comprising Immunoglobulin Constant Domains |
| 07/25/2013 | DE112011102638T5 Pharmazeutische Zusammensetzung und Verfahren zur Behandlung und Prävention der Krankheiten, die durch HIV verursacht werden oder mit HIV zusammenhängen Related pharmaceutical composition and method for the treatment and prevention of diseases caused by HIV or HIV |
| 07/25/2013 | CA2862424A1 Methods of using fgf19 modulators |
| 07/25/2013 | CA2861428A1 Stabilization of the anti-cd20 antibody rituximab |
| 07/24/2013 | EP2617736A1 Anti-glypican 3 antibody having improved kinetics in plasma |
| 07/24/2013 | EP2617735A2 Human anti TSHR antibodies |
| 07/24/2013 | EP2617734A1 Human anti TSHR antibodies |
| 07/24/2013 | EP2617730A1 Lung cancer identification marker |
| 07/24/2013 | EP2616812A1 Methods of treating autoimmune diseases with anti-fceri antibodies |
| 07/24/2013 | EP2616489A1 ANTI-huTNFR1 ANTIBODY |
| 07/24/2013 | EP2616488A2 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid |
| 07/24/2013 | EP2616100A1 Compositions and methods for treatment of drug resistant multiple myeloma |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN103221544A Oncolytic adenoviral vectors coding for monoclonal anti-CTLA-4 antibodies |
| 07/24/2013 | CN103221429A Therapeutic factor VIII antibodies |
| 07/24/2013 | CN103221428A 4-1BB binding molecules |
| 07/24/2013 | CN103221427A Anti-OX40 antibodies and methods of using the same |
| 07/24/2013 | CN103221426A Antibodies that bind myostatin, compositions and methods |
| 07/24/2013 | CN103221419A Lung cancer identification marker |
| 07/24/2013 | CN103221068A Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile |
| 07/24/2013 | CN103215652A Aflatoxin positive antibody gene bank, establishing method and application thereof, and aflatoxin recombinant single-chain antibody 1A7 |
| 07/24/2013 | CN103215292A Human Pcid2 protein soluble expression method, anti-human Pcid2 protein monoclonal antibody 2D7-F11, and hybridoma cell line secreting antibody |
| 07/24/2013 | CN103215232A Monoclonal antibody of Burkholderia gladioli pv. Alliicola and hybridoma cell line thereof |
| 07/24/2013 | CN103215231A Hybridoma cell strain 1H2, anti-ochratoxin A monoclonal antibody produced from same and application thereof |
| 07/24/2013 | CN103215230A Hybridoma cell strain AFM1B7, monoclonal antibody thereof and aflatoxin M1 flow lag immunization time-resolved fluorescence quick test kit |
| 07/24/2013 | CN103215229A Hybridoma cell strain AFB3G1, monoclonal antibody thereof and multi-detection line immunochromatography test strip for semi-quantitatively detecting aflatoxin B1 |
| 07/24/2013 | CN103215228A Expanding the eukaryotic genetic code |
| 07/24/2013 | CN103215227A Expanding the eukaryotic genetic code |
| 07/24/2013 | CN103214578A Novel humanized anti-CD22 antibody |
| 07/24/2013 | CN103214577A Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214575A Preparation method of carp amino acid transporter transport subunit rBAT rabbit anti-antiserum |
| 07/24/2013 | CN103214574A Method for preparing carp small peptide transporter protein PepT1 rabbit antiserum |
| 07/24/2013 | CN103214573A Anti human LOC339524 protein monoclonal antibody and a hybridomas cell strain and the purpose thereof |
| 07/24/2013 | CN103214572A Anti-sterigmatocystin monoclonal antibody |
| 07/24/2013 | CN103214571A Murine monoclonal antibody and preparation method and application thereof |
| 07/24/2013 | CN103214570A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or Nl-subtype and uses thereof |
| 07/24/2013 | CN103214557A Ezrin antigenic determinant polypeptide, preparation method of phosphorylated Thr566 antibody thereof and kit prepared from the antibody |
| 07/24/2013 | CN103212377A Preparation method of agarose immune magnetic microspheres and applications thereof |
| 07/24/2013 | CN103212084A IgG FC fragment for a drug carrier and method for the preparation thereof |
| 07/24/2013 | CN103212072A An antigen associated with lung cancers and lymphomas |
| 07/24/2013 | CN103212060A Application of protein and composition thereof in preparation of product used for preventing, diagnosing or treating EHEC (Enterohemorrhagic Escherichia Coli) infection |
| 07/24/2013 | CN102585004B AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity |
| 07/24/2013 | CN102471770B Antigen peptide and use thereof |
| 07/24/2013 | CN102388135B Protease for wound conditioning and skin care |
| 07/24/2013 | CN102120773B Dual specificity antibodies and methods of making and using |
| 07/24/2013 | CN102112611B Novel protease and use thereof |
| 07/24/2013 | CN101971023B Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine |
| 07/23/2013 | USRE44389 Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies |
| 07/23/2013 | US8492613 GNTIII expression in plants |
| 07/23/2013 | US8492529 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus GB glycoprotein, and antigen-binding fragment thereof |
| 07/23/2013 | US8492528 IL-B30 antibodies |
| 07/23/2013 | US8492527 Anti-VEGF antibodies |
| 07/23/2013 | US8492526 Effector function enhanced recombinant antibody composition |
| 07/23/2013 | US8492347 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 07/23/2013 | US8492119 Antibody to human IL-3 receptor alpha chain |
| 07/23/2013 | US8492097 Compositions and methods for human metapneumovirus monoclonal antibodies |
| 07/23/2013 | US8491914 Dock-and-lock (DNL) complexes for delivery of interference RNA |
| 07/23/2013 | US8491910 Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy |
| 07/23/2013 | US8491907 Human anti-Pseudomonas-aeruginosa It-2 antibodies derived from transgenic xenomouse |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | US8491905 KLK-13 antibody inhibitor for treating dry eye |
| 07/23/2013 | US8491904 Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography |
| 07/23/2013 | US8491902 Medicament comprising recombinant antibody against chemokine receptor CCR4 |
| 07/23/2013 | US8491901 Neutralizing anti-CCL20 antibodies |
| 07/23/2013 | US8491895 Methods of treating cancer with human monoclonal antibodies to CTLA-4 |
| 07/23/2013 | US8491893 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 07/23/2013 | US8491891 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such |
| 07/23/2013 | CA2720332C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 07/23/2013 | CA2567814C Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 07/23/2013 | CA2529583C Oxidoreductase from pichia capsulata |
| 07/23/2013 | CA2517439C Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 07/23/2013 | CA2514646C Factor viii polypeptide |
| 07/23/2013 | CA2321106C Group b streptococcus antigens |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/19/2013 | WO2012097313A2 Therapeutic antibodies against ror-1 protein and methods for use of same |
| 07/19/2013 | CA2858350A1 Therapeutic antibodies against ror-1 protein and methods for use of same |
| 07/18/2013 | WO2013106572A1 Bispecific antibody fragments for neurological disease proteins and methods of use |
| 07/18/2013 | WO2013106489A1 Humanized antibodies with ultralong cdr3s |
| 07/18/2013 | WO2013106485A2 Ultralong complementarity determining regions and uses thereof |
| 07/18/2013 | WO2013106338A1 Detecting latent tuberculosis infections |
| 07/18/2013 | WO2013105896A1 Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3 |
| 07/18/2013 | WO2013105856A1 Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
| 07/18/2013 | WO2013105707A1 Citrullinated protein-specific monoclonal antibody and hybridoma cell line producing same |
| 07/18/2013 | WO2013105013A1 Mutant antibodies and conjugation thereof |
| 07/18/2013 | WO2013104918A2 Binding molecule |
| 07/18/2013 | WO2013104804A2 Dual antigen-induced bipartite functional complementation |